Clinical Trial Update: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL) [Phase 1]

View source ↗

Summary

Phase I multicenter dose-escalation study of CAT-8015 in patients with Non-Hodgkin lymphoma; sponsored by MedImmune LLC, with the trial status listed as termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CAT-8015

Snippet

Sponsor: MedImmune LLC | Conditions: Lymphoma | Phase 1 | Status: TERMINATED